Elmiron 100 MG capsule 100S
Ended Awarded Last action
- Contract number
- SPE2DR26F7UX9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,340
Award facts
- Contract value 100% obligated
- $31,340.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $31,340.05 to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Elmiron 100 mg capsules in quantities of 100 units. This firm fixed-price, competitively awarded contract (without set-aside designation) is scheduled for completion by January 7, 2026, with performance taking place at the vendor's facility in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued at up to $999,999,999.00 through December 2031.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and healthcare systems, supplying a broad spectrum of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's role within the DLA supply chain supports military treatment facilities, veterans' healthcare programs, and other federal medical institutions globally. This delivery order for Elmiron, a medication used in the treatment of interstitial cystitis, exemplifies the routine pharmaceutical procurement operations conducted through the DLA's medical supply chain to ensure adequate medication inventory for federal healthcare beneficiaries.
Quick answers
Who was awarded contract SPE2DR26F7UX9?
SPE2DR26F7UX9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F7UX9 worth?
The government has obligated $31,340 on SPE2DR26F7UX9.
Is contract SPE2DR26F7UX9 an order under another contract?
Yes. SPE2DR26F7UX9 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7UX9 competed?
The extent of competition for SPE2DR26F7UX9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award